Mint Tower Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Mint Tower Capital Management’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$1.01M	–	409
2022 Q4	$1.01M	Buy	+100,000	New	+$999K	0.09%	182

Mint Tower Capital Management's EBAC Position: Q1 2023 in Review

Mint Tower Capital Management sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 100,000 shares — an estimated $1.01M sold.

Mint Tower Capital Management first reported a position in EBAC in Q4 2022 and held it in 1 quarter. The position peaked at $1.01M in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

Mint Tower Capital Management reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Mint Tower Capital Management sold 100,000 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $1.01M.
Mint Tower Capital Management first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q4 2022 and held it in 1 quarter.
Mint Tower Capital Management's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $1.01M in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Mint Tower Capital Management's 13F filing for Q1 2023, filed 9 May 2023.